Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs

PHILADELPHIA, Pa., April 29, 2025 (SEND2PRESS NEWSWIRE) — Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for a patented polymer nanoparticles technology designed for endotoxin removal from fluids such as water, protein solutions and plasma.

Other Story

enes